
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Clinical Diabetes
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1541961
This article is part of the Research Topic Prevention and Treatment Advancements in Diabetic Retinopathy View all 5 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Diabetic retinopathy (DR), one of the most common microvascular complications of diabetes mellitus (DM), remains to be a major driver of vision loss worldwide. Vitamin D has been reported to involve in DR pathogenesis but results have been inconsistent. We aimed to explore the relationship between blood 25-hydroxyvitamin D (25(OH)D) level and the risk of DR in patients with type 2 diabetes (T2DM). Methods: A total of 535 adults with T2DM from our department were included. Demographic information, biochemical data, 25(OH)D and sex hormones were collected. Fundus photography was performed to determine the presence of DR. Participants were grouped into DR group and non-DR (NDR) group according to the fundus examinations and four groups based on serum 25(OH)D levels as follows: normal, insufficient, deficient, and severely deficient. Multivariate logistic regression analysis was used to evaluate the association between 25(OH)D and risk of DR.Results: Males but not females with DR had significantly decreased levels of 25(OH)D (16.4±5.6ng/mL vs. 21.0±5.0ng/mL, P = 0.001) and increased proportion of severe 25(OH)D deficiency (14.8% vs. 6.7%, P = 0.022) compared to those without DR. Likewise, there was a gradually increasing percentage of DR with the reduction of 25(OH)D levels only in males (35.7%, 44.4%, 53.2%, 70.3%, P = 0.022). Intriguingly, total testosterone (TT) levels decreased markedly in males with DR (12.9±5.2nmol/L vs. 14.2±5.5nmol/L, P = 0.035) compared to their counterparts, and correlated positively with 25(OH)D (β = 0.161, P = 0.007), which was not occurred in females. After multivariate adjustment, we observed a significant inverse association between serum 25(OH)D and the occurrence of DR in males, showing that the adjusted ORs (AORs) and 95%CI for DR was 0.233 (0.070-0.779) in normal group, 0.280 (0.103-0.756) in insufficient group, 0.477 (0.196-1.164) in deficiency group with severely deficiency group as reference (P-trend = 0.003). However, such significant association was not observed in females (P-trend = 0.137). Conclusion: We concluded a gender-specific relationship between serum 25(OH)D and the incidence of DR in T2DM, supported by a significant inverse association between serum 25(OH)D and DR only in males, which could be mediated by marked reduction in TT levels.
Keywords: type 2 diabetes, Diabetic Retinopathy, 25-hydroxyvitamin D, Total testosterone, Gender-specific difference
Received: 09 Dec 2024; Accepted: 02 Apr 2025.
Copyright: © 2025 He, Kang, Mei, Zhou, Yin and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Cuiling Zhu, Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.